Paper Review Records
全部论文审稿周期
17 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
244
天
Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma
作者
Shenglan Li; Jialiang Lu; Zhuang Kang; Haiyan Yang; Wenbin Qian; Xi Chen; Xianggui Yuan; Miao Hu; Qiuqiu Shi; Xinglu Zhou; Feng Chen; Xiaowu Dong; Wenbin Li展开收起
作者单位
Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou 310022, China; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; HealZen Therapeutics Co., Ltd., Hangzhou 310018, China; ZJUCPS-HealZen Joint Laboratory of Drug Innovation and Transformation, Zhejiang University, Hangzhou 310058, China展开收起
140
天
CDK9 inhibition sensitizes intrinsically resistant BRAFV600E mutant colorectal cancer to BRAF inhibitors
作者
Ning Wei; Natalie Thielen; Mahshid Mohammadi; Muzaffer Ahmed Bhat; Terence Li; Yan Sun; Seiya Kitamura; Edward Chu; Chaoyuan Kuang展开收起
作者单位
Montefiore Einstein Comprehensive Cancer Center, Cancer Therapeutics Program, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA展开收起
49
天
Quercetin's antitumor effect in bladder cancer: Synergistic regulation of gut microbiota andl-serine metabolic pathway
作者
Zhao Zhai; Feiya Yang; Ru Feng; Haojian Zhang; Jingyue Wang; Hengtong Zuo; Xinyu Yang; Mengliang Ye; Hui Xu; Jiachun Hu; Jinyue Lu; Yi Zhao; Jianye Song; Yong Zhang; Yan Wang; Nianzeng Xing展开收起
作者单位
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100050, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100089, China展开收起
120
天
Preclinical evaluation of a novel tetrazine probe within a pretargeted delivery system for theranostics in HER2-positive tumor-bearing mice models
作者
Pengcheng Ma; Hui Tan; Qingyu Lin; Yuxia Liu; Hua Shen; Shuhua He; Hongxing Su; Zonghua Luo; Dai Shi; Dengfeng Cheng展开收起
作者单位
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; Department of Nuclear Medicine, Shanghai Clinical Research and Trial Center, Shanghai 201210, China; Department of Applied Chemistry, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China; School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China展开收起
109
天
APRIL-driven BCMA/TACI dual-targeted ligand–drug conjugates for selective and potent therapy of multiple myeloma
作者
Linling Zhou; Yanping Sun; Jie Bi; Jiaqi Zhao; Yinli Xia; Jun He; Jisheng Wang; Liqiang Pan展开收起
作者单位
School of Pharmacy and Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University, Hangzhou 310058, China; School of pharmacy, Hangzhou Medical College, Hangzhou 311399, China; The Third Hospital of Mianyang (Sichuan Mental Health center), Mianyang 612000, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天